CDKN2A and prostate adenocarcinoma: It seems that p16 is overexpressed rather than lost in a large proportion of prostate carcinomas as p16 protein expression was increased in a majority of adenocarcinomas of the prostate and in prostate intra-epithelial neoplasia (PIN) when compared with surrounding benign glands [7].